This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignee: Orion Corporation. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Susanna Ilmonen: Innovator in Pharmaceutical Composition
Introduction
Susanna Ilmonen is a notable inventor based in Espoo, Finland. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that target cancer treatment. Her work exemplifies the intersection of innovation and healthcare, showcasing the importance of research in improving patient outcomes.
Latest Patents
Susanna Ilmonen holds a patent for a pharmaceutical composition of darolutamide. This invention relates to an oral administration formulation, specifically in tablet form, that includes darolutamide or a pharmaceutically acceptable salt as the active ingredient. Darolutamide is recognized as a potent androgen receptor (AR) modulator, which is particularly useful in treating AR-dependent cancers, such as prostate cancer, and other diseases where AR antagonism is beneficial.
Career Highlights
Throughout her career, Susanna has been associated with Orion Corporation, a leading company in the pharmaceutical industry. Her role at Orion has allowed her to focus on innovative solutions that address critical health challenges. With her expertise, she has contributed to advancing therapeutic options for patients.
Collaborations
Susanna has collaborated with esteemed colleagues, including Juha Lintunen and Petteri Lyytinen. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to impactful innovations in the pharmaceutical sector.
Conclusion
Susanna Ilmonen's work in developing pharmaceutical compositions demonstrates her commitment to advancing cancer treatment. Her innovative contributions continue to play a vital role in the healthcare landscape, ultimately benefiting patients in need.